"How much does PBC treatment cost per year?"

"Annual costs range from about $2,000 with generic first-line medication to $30,000 or more if you need second-line brand-name drugs. Monitoring and specialist visits add to the total."

"Is primary biliary cholangitis treatment covered by insurance?"

"Yes. Insurers cover FDA-approved PBC medications, lab monitoring, and hepatology visits when medically necessary. You'll still owe copays, and brand-name second-line drugs may require prior authorization."

"What is the first-line treatment for PBC and what does it cost?"

"Ursodiol (UDCA) is first-line and inexpensive as a generic, often $30 to $150 a month. It's effective for most patients, making PBC one of the more affordable chronic liver conditions to treat early."

Primary Biliary Cholangitis Treatment Cost: PBC Care Prices for 2026

📋 Data from Medicare fee schedules & FAIR Health ✓ Reviewed by board-certified gastroenterologist 🔄 Updated May 2026

Primary biliary cholangitis used to be called primary biliary cirrhosis, and the name change wasn’t just cosmetic. It reflected the fact that, caught early and treated, most people with PBC never progress to cirrhosis at all. That’s encouraging for your health and your budget, because the first-line treatment happens to be cheap.

PBC is an autoimmune disease that slowly damages the bile ducts inside the liver. It overwhelmingly affects women, who make up about 9 in 10 cases according to the American Liver Foundation. Here’s what treatment costs.

The good news: first-line treatment is affordable

Most people start, and stay, on ursodiol (UDCA), a bile acid medication that slows the disease and is available as an inexpensive generic.

Treatment Component	Cost (Uninsured)	With Insurance
Ursodiol (UDCA) generic	$30 – $150/mo	$5 – $40/mo
Second-line drug (obeticholic acid)	$1,500 – $7,000/mo	$50 – $1,000/mo
Newer PPAR agonist meds	$1,000 – $5,000/mo	varies
Hepatologist visits	$200 – $450 each	$30 – $75 copay
Lab monitoring (per year)	$400 – $1,500	$200 – $700
FibroScan / imaging	$300 – $1,200	$75 – $300

How diagnosis works

PBC is usually caught through abnormal liver function tests, specifically a high alkaline phosphatase, followed by a blood test for a specific antibody (AMA). That antibody test is so reliable that many people never need a liver biopsy, which keeps diagnosis costs lower than for some other liver diseases.

Your hepatologist may order a FibroScan or abdominal ultrasound to gauge how much, if any, scarring exists.

Key Takeaway

Roughly two-thirds of PBC patients respond well to inexpensive generic ursodiol alone, keeping their annual drug costs under a few hundred dollars. The big expense only kicks in for the minority who don’t respond and need second-line brand-name therapy. So your costs hinge largely on how your liver responds to that first, cheap medication, which you won’t know until you try it.

When second-line drugs are needed

If ursodiol doesn’t bring your numbers down enough, doctors add a second-line medication. These newer drugs are far more expensive, sometimes thousands of dollars a month before insurance. The FDA has approved several second-line options in recent years, expanding choices but also raising the potential cost ceiling.

The reassuring part: manufacturer copay assistance and patient support programs can bring out-of-pocket costs for these drugs down dramatically, sometimes to a small monthly copay. Always ask the manufacturer and your specialist about these programs before assuming you can’t afford a drug.

Ongoing monitoring

PBC is a lifelong condition, so monitoring is a recurring cost. Expect blood work every few months early on, then every 6 to 12 months once stable, plus periodic imaging to screen for liver scarring and cancer risk. Budget $200 to $700 a year for monitoring with insurance.

Managing symptoms like itching and fatigue may add small medication costs, but these are usually modest.

Don’t skip monitoring just because you feel fine, PBC often progresses silently for years. Stopping your medication or missing labs to save money can let damage accumulate undetected, eventually leading to cirrhosis. Treating cirrhosis costs vastly more than maintaining a stable PBC patient, so consistent, inexpensive care is the smart financial play.

Advanced disease costs

If PBC does progress to cirrhosis, costs climb sharply, complications, more intensive monitoring, and potentially a transplant evaluation. This is exactly the scenario early treatment is designed to prevent, which is why staying on cheap first-line therapy and keeping up with labs is so cost-effective.

How to keep costs down

Use generic ursodiol, it’s just as effective as brand versions.
Ask about copay assistance before filling any expensive second-line prescription.
Stick to your monitoring schedule to avoid costly late-stage surprises.
See a hepatologist familiar with PBC, proper management prevents expensive progression.

The bottom line

For most people, PBC is one of the more affordable chronic liver diseases to manage, often under $2,000 a year thanks to cheap, effective generic medication. Costs only spike for the minority who need second-line brand-name drugs, and even then, assistance programs can soften the blow. Catching PBC early and staying on treatment keeps both the disease and your bills under control.

Disclaimer: Cost figures are estimates for US patients based on 2025–2026 published fee schedules, Medicare data, and FAIR Health benchmarks. Actual costs vary by location, provider, plan, and procedure complexity. This site does not provide medical advice. Always verify costs with your provider before scheduling.